Drug | Page 265 of 280 | SpiritIndia.com

Restless Legs Syndrome :: Requip – ropinirole for Restless Legs Syndrome

The Food and Drug Administration has approved Requip (ropinirole) to treat moderate to severe Restless Legs Syndrome (RLS). The drug was first approved for Parkinson?s disease in 1997.

Gangrene :: A chronic disease – gangrene

Gangrene is the term used to describe the decay or death of an organ or tissue caused by a lack of blood supply. It is a complication resulting from infectious or inflammatory processes, injury, or degenerative changes associated with chronic diseases, such as diabetes mellitus.

Whooping Cough :: Vaccine to protect adolescents from whooping cough

The Food and Drug Administration (FDA) approved the first combination vaccine that provides a booster immunization against pertussis (whooping cough) in combination with tetanus and diphtheria for adolescents. The vaccine will be marketed as Boostrix by GlaxoSmithKline (GSK) in Philadelphia, Pa.

Respiratory :: Excess oxygen worsens lung inflammation

Research performed at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has revealed that oxygen therapy aimed at helping mice with acute lung inflammation breathe paradoxically worsened their illness. The researchers say excess oxygen appears to thwart a natural process that limits lung tissue damage. They overcame this deleterious side effect, however, by adding an inhaled anti-inflammatory drug to the oxygen therapy.

Drug Abuse :: Alprazolam, Xanax in insomnia and daytime anxiety

Drugs marketed in the United States that affect central nervous system function, Alprazolam/Xanax is among the most widely prescribed medications. Xanax is a longer duration Benzodiazepine which is prescribed to treat insomnia in patients with daytime anxiety or patients with Generalized Anxiety Disorder (GAD) and Panic Disorders.

Meditation :: Meditation calms the mind, lengthens life

Increasing evidence suggests that transcendental meditation may not only reduce stress, but also may help adults with high blood pressure to live longer, according to a new study.

Depression :: Requests for medications boost prescribing for depression

Researchers funded by the National Institute of Mental Health (NIMH), part of the National Institutes of Health, have found that requests from patients for medications have a “profound effect” on physicians prescribing for major depression and adjustment disorder. These findings indicate that direct-to-consumer (DTC) marketing of prescription medications for depression may exert significant influence on treatment decisions.

Homeopathic Medicine :: Aconitum Napellus, Monkshood – Ranunculaceae

It is generally indicated in acute or recent cases occurring in young persons, especially girls, of a full, plethoric habit who lead a sedentary life; persons easily affected by atmospheric changes; dark hair and eyes, rigid muscular fibre.

Diabetes :: Diet, exercise best for preventing pre-diabetes

Lifestyle changes are more effective than drug treatment in preventing metabolic syndrome, the cluster of disorders that can lead to diabetes and heart disease, according to a new study.

Gingivitis :: New oral rinse to help treat gingivitis

The Food and Drug Administration (FDA) approved a new prescription treatment for gingivitis, a common gum disease that affects most adults at some point in their lives. The Decapinol Oral Rinse treats gingivitis by reducing the number of bacteria that attach to tooth surfaces and cause dental plaque. Decapinol is approved for use in persons 12 years of age or older when routine oral hygiene is not adequate to prevent gingivitis. Decapinol is not recommended for use by pregnant women.